NPPB and cardiovascular disorder: Previous studies showed that existing biomarkers of cardiovascular diseases, such as cardiac troponin and N-terminal proB-type natriuretic peptide (NT-proBNP), could be employed to assess the severity of OHCM in terms of myocardial damage and heart failure (12).